to page content
to site navigation
The Resource Center has all the info you'll need From content to user feedback, the resource center has the information you need for every level of the entrepreneurial process.
Early stage company entrepreneurs have been warned about a "valley of death" for funding. Read about whether it's real or just a myth.
A new Kauffman Foundation report points to what might be a long-term bridge over the most difficult funding stage for startups—the 'Valley of Death.' In that timeframe, after entrepreneurs have exhausted friends, family, and personal credit and before they're ready for external funding, some startups struggle to raise enough capital to stay alive.
Venture capital investment in healthcare startups increased last year in the Midwest, but the dollar amount raised lags behind earlier years. Read more about the state of venture capital investing in healthcare startups.
When it comes to funding for life science companies, it isn't a matter of angel investing versus venture capital. Read about funding sources for startups.
Local investing could be the answer to the problem of dealing with big banks and the way they do business. Read more about this funding alternative for startups.
Healthcare investing saw a five-quarter high at the end of 2011, with medical devices getting the largest number of deals. Read more about the state of healthcare venture capital today.
The National Institutes of Health has billions of dollars designated for biotech research. Read about how to win NIH research grants.
It's more than possible these days to raise capital in small doses, but such funding techniques mean entrepreneurs must know what these investors want to see before they write a check. As Congress formalizes a sweeping crowd funding bill, it's time to get your ducks in a row.
A NASA-funded academic consortium is on the hunt for a few good bioscience ideas -- and it's now offering funding opportunities to healthcare startups that can provide them.
Venture capital investing in health IT is expected to increase, while investing in medical devices and biopharmaceuticals drops, according to a recent National Venture Capital Association survey. Read more about why VCs are favoring health IT companies.
Want to get connected? Sign up to receive regular news, polls and updates from The Kauffman Foundation.